Skip to menu Skip to content Skip to footer

Developing a thermal-stable nanoparticle-based oral vaccine: towards commercial reality (2021-2022)

Experts

Dr Hao Song

NHMRC Emerging Leadership Fellow
Australian Institute for Bioengineering and Nanotechnology
Hao Song
Hao Song